Cargando…
Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line
Autores principales: | Agathangelidis, Andreas, Scarfò, Lydia, Barbaglio, Federica, Apollonio, Benedetta, Bertilaccio, Maria Teresa Sabrina, Ranghetti, Pamela, Ponzoni, Maurilio, Leone, Gabriella, De Pascali, Valeria, Pecciarini, Lorenza, Ghia, Paolo, Caligaris-Cappio, Federico, Scielzo, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519319/ https://www.ncbi.nlm.nih.gov/pubmed/26222697 http://dx.doi.org/10.1371/journal.pone.0134748 |
Ejemplares similares
-
Establishment and Characterization of PCL12, a Novel CD5(+) Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015) -
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models
por: Bianco, Mimma, et al.
Publicado: (2016) -
PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target
por: Sbrana, Francesca Vittoria, et al.
Publicado: (2023) -
Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents
por: Barbaglio, Federica, et al.
Publicado: (2020) -
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
por: Valsecchi, Roberta, et al.
Publicado: (2020)